United States · FDA National Drug Code directory

NILOTINIB

Source ingredient · 23 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 70709-191_8991c94b-a4c1-46f8-aafe-a106aba4f8cf

CAVHANZA

TABLET, ORALLY DISINTEGRATING / Cycle Pharmaceuticals Ltd

United States · Source reference 70709-192_8991c94b-a4c1-46f8-aafe-a106aba4f8cf

CAVHANZA

TABLET, ORALLY DISINTEGRATING / Cycle Pharmaceuticals Ltd

United States · Source reference 24338-154_62029a35-74af-47bc-9b7b-93dcaddfd278

DANZITEN

TABLET / Azurity Pharmaceuticals, Inc.

United States · Source reference 24338-155_62029a35-74af-47bc-9b7b-93dcaddfd278

DANZITEN

TABLET / Azurity Pharmaceuticals, Inc.

United States · Source reference 31722-779_44065ee4-1b6c-f3ef-e063-6394a90a797a

Nilotinib

CAPSULE / Camber Pharmaceuticals, Inc.

United States · Source reference 31722-780_44065ee4-1b6c-f3ef-e063-6394a90a797a

Nilotinib

CAPSULE / Camber Pharmaceuticals, Inc.

United States · Source reference 60505-3801_613e32f2-69e7-1399-da53-ecc0ae6def94

Nilotinib

CAPSULE / Apotex Corp.

United States · Source reference 60505-3802_613e32f2-69e7-1399-da53-ecc0ae6def94

Nilotinib

CAPSULE / Apotex Corp.

United States · Source reference 60505-3803_613e32f2-69e7-1399-da53-ecc0ae6def94

Nilotinib

CAPSULE / Apotex Corp.

United States · Source reference 69097-030_d748f03e-56ba-48e2-ae13-e8e74fac55e7

Nilotinib

CAPSULE / Cipla USA Inc.

United States · Source reference 69097-031_d748f03e-56ba-48e2-ae13-e8e74fac55e7

Nilotinib

CAPSULE / Cipla USA Inc.

United States · Source reference 69097-032_d748f03e-56ba-48e2-ae13-e8e74fac55e7

Nilotinib

CAPSULE / Cipla USA Inc.

United States · Source reference 76282-788_dbdd9603-ecc5-472c-8ce9-7cec9aae11f9

Nilotinib

CAPSULE / EXELAN PHARMACEUTICALS INC.

United States · Source reference 76282-789_dbdd9603-ecc5-472c-8ce9-7cec9aae11f9

Nilotinib

CAPSULE / EXELAN PHARMACEUTICALS INC.

United States · Source reference 76282-790_dbdd9603-ecc5-472c-8ce9-7cec9aae11f9

Nilotinib

CAPSULE / EXELAN PHARMACEUTICALS INC.

United States · Source reference 17088-0226_ae0e351a-f723-4cc6-846c-77dc11471d6f

nilotinib

CAPSULE / Novartis Pharma Stein AG

United States · Source reference 17088-0233_ae0e351a-f723-4cc6-846c-77dc11471d6f

nilotinib

CAPSULE / Novartis Pharma Stein AG

United States · Source reference 17088-0240_ae0e351a-f723-4cc6-846c-77dc11471d6f

nilotinib

CAPSULE / Novartis Pharma Stein AG

United States · Source reference 72205-237_13b46e09-62d2-4ce9-b3c0-deafcb1f1842

nilotinib

CAPSULE / Novadoz Pharmaceuticals LLC

United States · Source reference 72205-238_13b46e09-62d2-4ce9-b3c0-deafcb1f1842

nilotinib

CAPSULE / Novadoz Pharmaceuticals LLC

United States · Source reference 72205-239_13b46e09-62d2-4ce9-b3c0-deafcb1f1842

nilotinib

CAPSULE / Novadoz Pharmaceuticals LLC

United States · Source reference 73190-033_4c0bc87a-7a6c-af1e-e063-6394a90a5495

nilotinib

CAPSULE / AvKARE

United States · Source reference 73190-034_4c0bc87a-7a6c-af1e-e063-6394a90a5495

nilotinib

CAPSULE / AvKARE

Browse ingredients in United States →